What is Vir Biotechnology, Inc.'s equity securities?

Vir Biotechnology, Inc. (VIR) reported equity securities of $5.9M in Q1 2026.

How has Vir Biotechnology, Inc.'s equity securities changed year-over-year?

Vir Biotechnology, Inc.'s equity securities decreased by 44.9% year-over-year, from $10.7M to $5.9M.

What is the long-term trend for Vir Biotechnology, Inc.'s equity securities?

Over 2 years (2023 to 2025), Vir Biotechnology, Inc.'s equity securities has grown at a -21.5% compound annual growth rate (CAGR), from $9.85M to $6.08M.

What does equity securities mean?

Insurance company investments in equity securities (stocks, equity funds) measured at fair value.

Vir Biotechnology, Inc. VIR Equity securities

Equity securities at other companies

Consensus Cloud Solutions, Inc.CCSI

$8M0.0%

Peoples Financial ServicesPFIS

$3.05M+22.1%

Liberty GlobalLBTYB

$1.5B-49.6%

Univest Financial CorporationUVSP

$2.9M+73.8%

Metropolitan Bank Holding Corp.MCB

$5.63M+7.7%

Investors Title CompanyITIC

$46.36M+34.0%

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.67B+130%

Enterprise value$1.48B+228%

P/S25.4×-9.2×

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s equity securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s equity securities?: Vir Biotechnology, Inc. (VIR) reported equity securities of $5.9M in Q1 2026.
How has Vir Biotechnology, Inc.'s equity securities changed year-over-year?: Vir Biotechnology, Inc.'s equity securities decreased by 44.9% year-over-year, from $10.7M to $5.9M.
What is the long-term trend for Vir Biotechnology, Inc.'s equity securities?: Over 2 years (2023 to 2025), Vir Biotechnology, Inc.'s equity securities has grown at a -21.5% compound annual growth rate (CAGR), from $9.85M to $6.08M.
What does equity securities mean?: Insurance company investments in equity securities (stocks, equity funds) measured at fair value.